Psyence Biomedical Ltd.

NASDAQ: PBM · Real-Time Price · USD
3.22
-0.13 (-3.88%)
At close: Aug 15, 2025, 3:59 PM
3.28
1.63%
After-hours: Aug 15, 2025, 07:36 PM EDT

Psyence Biomedical Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Cash & Equivalents
762.8K 128.68K 648.28K
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a 257.73M 255M
Other Long-Term Assets
n/a n/a 248.65K
Receivables
41.75K 149.37K 39.55K
Inventory
n/a n/a -39.55K
Other Current Assets
29.61K 29.56K 324.94K
Total Current Assets
1.13M 1.21M 973.22K
Property-Plant & Equipment
5.49K n/a n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
5.49K 257.73M 255.25M
Total Assets
1.13M 258.93M 256.22M
Account Payables
562.35K 1.63M 36.89K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
10.45M n/a n/a
Other Current Liabilities
968.51K 12.48M n/a
Total Current Liabilities
12.1M 14.27M 68.7K
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 19.51M
Total Liabilities
12.1M 14.27M 19.58M
Total Debt
10.45M n/a n/a
Common Stock
46.13M 258.55M 255M
Retained Earnings
-57.46M -13.9M -18.36M
Comprehensive Income
361.06K n/a n/a
Shareholders Equity
-10.97M 244.66M 236.65M
Total Investments
-29.61K 257.73M 255M